TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04857060

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACP Educator led, video assisted discussion
Description: For hospitalized patients identified by a defined EHR algorithm, an ACP Educator will meet with the patient in the hospital to provide primary palliative care services such as goals-of-care conversations and clinician communication by leveraging certified video decision aids.
Study: NCT05622396

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction
Description: Inspired by the standard Mindfulness Based Stress Reductio program, the study MAdaPARK is a 8 week program with weekly sessions of 2h30 and a full day of practice designed from the analysis of the post-program interviews carried out as part of the M-PARK study,as well as the reflections of the working group specially set up for this purpose. Several areas of adaptation have been identified: shorter mediations, a break time during the sessions, more times for exchanges, a more developed practice in movement, and finally, more important work based on self-esteem and self-compassion.
Study: NCT06214572

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic therapy (Gemcitabine plus Cisplatin)
Description: Participants will receive one of the following Gemcitabine-based systemic therapy alone:~Gemcitabine 1000mg/m2 and Cisplatin 25 mg/m2, each administered on Days 1 and 8 every 3 weeks (q3w)~Duration: 3 months (in addition to 3 months previously received)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic therapy (Gemcitabine plus Cisplatin)
Description: Participants will receive one of the following Gemcitabine-based systemic therapy alone:~Gemcitabine 1000mg/m2 and Cisplatin 25 mg/m2, each administered on Days 1 and 8 every 3 weeks (q3w)~Duration: 3 months (in addition to 3 months previously received)

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: RT
Description: Participants will receive radiation therapy in addition to systemic therapy Hypofractionated external image guided radiation to a dose of 40-55Gy in 10 sessions (up to 60Gy in 15 sessions) over 2-3 weeks.~This is followed by systemic therapy as in the Systemic therapy alone arm.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic therapy (Gemcitabine plus oxaliplatin)
Description: Gemcitabine 1000 mg/m2 and oxaliplatin 100 mg/m2 IV infusion on days 1 and 8 q2w.~Duration: 3 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic therapy (Gemcitabine plus oxaliplatin)
Description: Gemcitabine 1000 mg/m2 and oxaliplatin 100 mg/m2 IV infusion on days 1 and 8 q2w.~Duration: 3 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic therapy (Gemcitabine plus Cisplatin plus Durvalumab)
Description: Durvalumab 1500 mg via intravenous (IV) infusion q4w, starting on Cycle 1 in combination with cisplatin 25 mg/m2 and gemcitabine 1000 mg/m2 each administered on Days 1 and 8, q3w.~Duration 3 months Durvalumab (12 months)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic therapy (Gemcitabine plus Cisplatin plus Durvalumab)
Description: Durvalumab 1500 mg via intravenous (IV) infusion q4w, starting on Cycle 1 in combination with cisplatin 25 mg/m2 and gemcitabine 1000 mg/m2 each administered on Days 1 and 8, q3w.~Duration 3 months Durvalumab (12 months)
Study: NCT04944147

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Description: Anodal transcranial direct current stimulation (tDCS), 9 sessions with 20 minutes stimulation each (2 mA)
Study: NCT05954182

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Intervention
Description: This is a virtual, group cognitive intervention. 12 live, weekly sessions will occur during the first 3 months of the study. Groups will be made up of 5-10 participants and will be led by a neuropsychologist. These sessions will include education on the brain and cognitive function as it relates to epilepsy, as well as compensatory strategies for use in daily life. After the 12 sessions, participants will be asked to continue to practice what they learned for the next nine months until their participation ends.
Study: NCT04944147

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sham tDCS
Description: Sham transcranial direct current stimulation (tDCS), 9 sessions with 30 sec stimulation each (2 mA) to ensure blinding of participants

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham tDCS
Description: Sham transcranial direct current stimulation (tDCS), 9 sessions with 30 sec stimulation each (2 mA) to ensure blinding of participants

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive cognitive training
Description: Intensive cognitive training of a letter memory updating task, 9 sessions
Study: NCT06214572

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic therapy (Gemcitabine plus cisplatin plus nab-paclitaxel)
Description: Gemcitabine 800 mg/m2, cisplatin, 25 mg/m2, and nab-paclitaxel 100 mg/m2, on days 1 and 8, q3w Duration: 3 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic therapy (Gemcitabine plus cisplatin plus nab-paclitaxel)
Description: Gemcitabine 800 mg/m2, cisplatin, 25 mg/m2, and nab-paclitaxel 100 mg/m2, on days 1 and 8, q3w Duration: 3 months
Study: NCT04914377

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQ Formula/Tab
Description: TQ Formula will be administered as an oral dose daily. The dose planned in this study is 3 g per day (3 500mg capsules to be taken twice daily).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: TQ Formula/Tab
Description: TQ Formula will be administered as an oral dose daily. The dose planned in this study is 3 g per day (3 500mg capsules to be taken twice daily).
Study: NCT05902013

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: laryngoscopy
Description: laryngoscopy for nasotracheal intubation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: laryngoscopy
Description: laryngoscopy for nasotracheal intubation
Study: NCT05359406

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: a combination therapy including tislelizumab
Description: For liver/pulmonary metastasis, the treatment plan is to implement large fraction radiotherapy for 4-8 times. For primary rectum lesion, short-course radiotherapy regimen through intensity-modulated radiotherapy will be applied with dose of 25Gy/5Fx. Immunotherapy contains anti-PD-1 monoclonal antibody, Tislelizumab(200mg, d1, q3w, i.v). For patients with RAS or BRAF mutation, chemotherapy adopts FOLFOX+BEV plan. For patients without RAS or BRAF mutation, chemotherapy adopts FOLFIRI+CET plan.~Patients will be followed for safety during the study. The safety follow-up period is defined as 90 days after the last dose of tislelizumab. Safety related data will be collected from the time of signing the informed consent until the end of the safety follow-up period or the start of new therapy.
Study: NCT04944147

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Intensive cognitive training
Description: Intensive cognitive training of a letter memory updating task, 9 sessions

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Progressive muscle relaxation (PMR)
Description: Standardized instructed PMR training, 9 sessions
Study: NCT05023057

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multidomain intervention
Description: For 24 weeks, participants will receive cognitive training using the tablet PC application twice a week, exercise 3 times a week, nutrition education 12 times, anthropometric measurements and alcohol and smoking monitoring every 4 weeks, motivation reinforcement training 4 times.
Study: NCT05907993

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen 800 mg
Description: Intravenous Ibuprofen versus intravenous Ketorolac for postoperative pain relief
Study: NCT06441851

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Videolaparoscopic Partial Nephrectomy
Description: Videolaparoscopic partial nephrectomy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robot-assisted Partial Nephrectomy
Description: Robot-assisted partial nephrectomy
Study: NCT05658575

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapansutrile
Description: An initial loading dose of 2000 mg dapansutrile on Day 1 followed by a maintenance regimen of 1000 mg dapansutrile twice daily starting 12 hours later through the second dose on Day 7, inclusive.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Tablet
Description: An initial loading dose of matching placebo (to mimic dapansutrile dosing) on Day 1 followed by a maintenance regimen of matching placebo twice daily starting 12 hours later through the second dose on Day 7, inclusive.
Study: NCT05760820

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SES Children (SES Mini & SES Nxt)
Description: SES Children (SES Mini \& SES Nxt) is a digital intervention aiming to develop children's self-efficacy and ability to overcome the challenges that come with a divorce and major life crises, thereby reducing the negative impacts of these on children's overall mental health and wellbeing. The intervention formatted to specific age groups between the ages of 3 and 17, and is relevant to all children whose parents have split up, regardless of whether they experience a higher or lower degree of conflict between the parents, a or higher or lower degree of strain from the judicial divorce.~The intervention covers a variety of topics, including when my parents fight, a bonus family, packing the overnight bag, to live in two places, and children's rights.
Study: NCT05342467

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemeprost 1 Mg Vaginal Pessary
Description: Intravaginal gemeprost 1 mg inserted 3 hourly for maximum of 5 doses in 24 hours

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemeprost 1 Mg Vaginal Pessary
Description: Intravaginal gemeprost 1 mg inserted 3 hourly for maximum of 5 doses in 24 hours

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dinoprostone 3 mg
Description: Intravaginal dinoprostone 3 mg inserted 4 hourly for maximum of 3 doses in 24 hours

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dinoprostone 3 mg
Description: Intravaginal dinoprostone 3 mg inserted 4 hourly for maximum of 3 doses in 24 hours
Study: NCT06320938

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neuroscience-Based Pain Education Combined with Home Exercise Program
Description: Neuroscience-Based Pain Education and Home Exercises will be applied.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial Induction Techniques Combined with Home Exercise Program
Description: Myofascial Induction Techniques and Home Exercises will be applied.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercises Group
Description: Home Exercises wiil be applied
Study: NCT04845256

Intervention type: DEVICE
Intervention: SOMAVAC 100 Sustained Vacuum System
Description: Evaluate performance of sustained vacuum system compared to manual suction bulbs
Study: NCT05784181

Intervention type: DEVICE
Group type: OTHER
Intervention: bipolar transurethral resection and Laser enaculation by holmium: YAG laser
Description: Laser enaculation by holmium: YAG laser

Intervention type: DEVICE
Group type: OTHER
Intervention: bipolar transurethral resection and Laser enaculation by holmium: YAG laser
Description: Laser enaculation by holmium: YAG laser
Study: NCT05225909

Intervention type: DEVICE
Intervention: Endoscopic retrograde Cholangio-pancreatography (ERCP) with aScope (Single use duodenoscope
Description: ERCP Procedure will be done using aScope. We will assess the performance of the aScope.
Study: NCT06328842

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Oro-esophageal Tube Feeding
Description: The specific procedure was as follows: the infant was placed in a semi-recumbent or sitting position with the head fixed. Before each feeding, the infant's oral and nasal secretions were to be cleared. An intermittent oro-esophageal tube was appropriately lubricated with water on the head part. The professional medical staff held the tube and slowly inserted it through one side of the mouth into the upper part of the esophagus. The depth of insertion depended on the patient's age and height. After each feeding, the tube was immediately removed, and the patient was held upright for at least 30 minutes in case of reflux.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nasogastric Tube Feeding
Description: Nasogastric Tube Feeding were used for feeding to provide nutritional support. Each feeding was administered by a nurse using the infant's mother's breast milk through the tube. The amount of each feeding varied from 20 to 100 ml depending on the age of the infant, with feedings given every 2 to 3 hours, approximately 10 times per day. The duration of each feeding procedure ranged from 10 to 20 minutes. The total daily intake ranged from 200 to 1000 ml. Each tube was kept indwelling for 5 to 7 days. When the tube needed to be replaced, it was removed after the last feeding of a day and a new tube was to be inserted through the other nostril on the following morning to continue the nutritional support.
Study: NCT05735509

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rubber dam
Description: Intraoral impressions can be taken with rubber dam in place. The care provider will take two impressions, one with the rubber dam in place and one without. The investigator will randomly chose one of the two impressions for crown manufacturing, and the crown will be delivered by the care provider blindly

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Rubber dam
Description: Intraoral impressions can be taken with rubber dam in place. The care provider will take two impressions, one with the rubber dam in place and one without. The investigator will randomly chose one of the two impressions for crown manufacturing, and the crown will be delivered by the care provider blindly
Study: NCT04406987

Intervention type: PROCEDURE
Intervention: decompression
Description: surgical technique for neural decompression varied based on surgeon's preference, but always with preservation for spinous processes. Either open with or without microscope or using tubular retractors.

Intervention type: PROCEDURE
Intervention: fusion
Description: fusion techniques consisted besides decompression of additional implantation of pedicle screws with rods, with or without intervertebral fusion and cage(s). Non-instrumented technique with allograft bone. Fusion technique on surgeon's discretion.
Study: NCT06084364

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Injection of triamcinolone acetonide into the CMC-1 joint
Description: intraarticular injection with triamcinolone acetonide

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multimodal Occupational therapy for CMC-1 joint OA
Description: Patient education, instructions about hand exercises, orthosis and training

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intraarticular injection with saline
Study: NCT04538157

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment
Description: A CGA is a diagnostic and therapeutic intervention which initially identifies an older person's medical, functional, psychosocial problems and then tailors coordinated management plans to address them.
Study: NCT05745155

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Senti Wear device system with Senti-AI subsystem
Description: This device is a smart garment, with a similar form to a T-Shirt, jacket or tabard, embedded with ten sensor modules (nine acoustic sensors, one kinetic sensor - all able to detect signals from the chest wall and underlying structures, including the lungs) encased in silicone; the device is charged via a charging port in the garment. The device has two modes of operation: recording mode and charging mode. The device is internally (battery) powered during recording mode and mains-powered during charging mode. The device is accompanied by cloud-based software to listen to both contemporaneous and historically recorded breath sounds, for each Senti patient. To use the device, the user puts the garment on (overhead, like a T-Shirt, before joining the back piece to the front like a tabard).~Additionally, Senti-AI adds an anomaly burden score and an alert flag for review against each acoustic record for each patient.
Study: NCT06450886

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ulviprubart (ABC008)
Description: All eligible subjects, regardless of treatment assignment or dose level in their initial study, will be administered ulviprubart at a dose of 2.0 mg/kg via subcutaneous (SC) injection Q8W.
Study: NCT05140395

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ABTEST card
Description: Pre transfusional control with the referent ABTEST card and the in study ABDTEST Card
Study: NCT04047056

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Labor Kinesiotherapy
Description: The intervention group will perform 5 minutes of warm-up with free active exercises, 10 minutes of specific resistance exercises for the cervical and upper limbs and 5 minutes of stretching and muscle relaxation.The initial free active exercises will be performed in 3 sets of 15 repetitions; Resistance exercises will be performed in 3 sets of 10 repetitions and stretching will be performed in 3 sets of 30 seconds.~Regarding the intervals between exercises, active recovery will be adopted to counteract the effects of muscle fatigue.
Study: NCT06319001

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Low-volume high intensity exercise
Description: This intervention will consist of 10 x 10-second interval sprints on a stationary bicycle interspersed with 50-second breaks between repetitions. The cycle resistance will be adjusted to the level equaling the highest power output, which will be determined during warm-up sprints.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-volume high intensity exercise
Description: This intervention will consist of 10 x 10-second interval sprints on a stationary bicycle interspersed with 50-second breaks between repetitions. The cycle resistance will be adjusted to the level equaling the highest power output, which will be determined during warm-up sprints.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Combined intermittent sauna and cold water bath (sauna+cold bath).
Description: This intervention will consist of 3x10 min bouts in the dry sauna interspersed with 2x 60 seconds of cold water immersion up to the neck.
Study: NCT04047056

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Labor Kinesiotherapy
Description: The intervention group will perform 5 minutes of warm-up with free active exercises, 10 minutes of specific resistance exercises for the cervical and upper limbs and 5 minutes of stretching and muscle relaxation.The initial free active exercises will be performed in 3 sets of 15 repetitions; Resistance exercises will be performed in 3 sets of 10 repetitions and stretching will be performed in 3 sets of 30 seconds.~Regarding the intervals between exercises, active recovery will be adopted to counteract the effects of muscle fatigue.
Study: NCT06541808

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mechanical Vagus Nerve Stimulation (Low Intensity)
Description: The stimulation consists of a combination of normal neck movements, performed in a comfortable supine position, which can selectively stimulate the VN. In particular. The participant will be stimulated supine on a comfortable massage/treatment bed with the experimenter standing at the cranial short side of the bed. All the neck movements will be gently performed with a combination of upper cervical flexion and contralateral lateral flexion to load the intracranial portion of the vagus nerve. The ipsilateral neck rotation will be combined to load the cervical tract of the nerve. Keeping the participant's head in the final movements combination the upper abdomen will be gently moved caudally to load the thoracic tract and intermittent gentle impulses 1 each second will be administered. The stimulation will be provided for 2 consecutive minutes for each side, only once for the experiment duration.
Study: NCT06319001

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined intermittent sauna and cold water bath (sauna+cold bath).
Description: This intervention will consist of 3x10 min bouts in the dry sauna interspersed with 2x 60 seconds of cold water immersion up to the neck.
Study: NCT02056834

Intervention type: DEVICE
Intervention: chronOS Inject
Description: chronOS Inject is used as bone void filler in internal fixation of proximal tibial fractures
Study: NCT06541808

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mechanical Vagus Nerve Stimulation (Intermediate Intensity)
Description: The stimulation consists of a combination of normal neck movements, performed in a comfortable supine position, which can selectively stimulate the VN. In particular. The participant will be stimulated supine on a comfortable massage/treatment bed with the experimenter standing at the cranial short side of the bed. All the neck movements will be gently performed with a combination of upper cervical flexion and contralateral lateral flexion to load the intracranial portion of the vagus nerve. The ipsilateral neck rotation will be combined to load the cervical tract of the nerve. Keeping the participant's head in the final movements combination the upper abdomen will be gently moved caudally to load the thoracic tract and intermittent gentle impulses 1 each second will be administered. The stimulation will be provided for 3 sessions of 2 minutes, with 2 minutes of rest for each side. stimulation will be provided only once for the experiment duration.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mechanical Vagus Nerve Stimulation (High Intensity)
Description: The stimulation consists of a combination of normal neck movements, performed in a comfortable supine position, which can selectively stimulate the VN. In particular. The participant will be stimulated supine on a comfortable massage/treatment bed with the experimenter standing at the cranial short side of the bed. All the neck movements will be gently performed with a combination of upper cervical flexion and contralateral lateral flexion to load the intracranial portion of the vagus nerve. The ipsilateral neck rotation will be combined to load the cervical tract of the nerve. Keeping the participant's head in the final movements combination the upper abdomen will be gently moved caudally to load the thoracic tract and intermittent gentle impulses 1 each second will be administered. The stimulation will be provided for 8 consecutive minutes for each side, only once for the experiment duration.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham mechanical Vagus Nerve Stimulation
Description: Participants will be treated with a fake vagus stimulation by letting the operator hold the neck of the participant in one hand and placing the other hand on the abdomen without any stretch on the vagus nerve